Metraipolis › archive › dc_e654688eaa97

Is Routine Monitoring of TNF-α Inhibitor Levels and Antibodies in Pediatric IBD Justified in the Era of Personalized Medicine — Europe PMC PMID:42278960

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42278960
DOI
10.3390/jcm15114098
License (as archived)
solo-consultazione
Archived
2026-11-01T06:42:04.872Z
SHA-256 of the archived text
1640b05e54acc443b14a134cb2496e57fc1727ab18da65c37510445843e4d771
Stable URL of this page
https://metraipolis.com/documento/dc_e654688eaa97

How to cite

Is Routine Monitoring of TNF-α Inhibitor Levels and Antibodies in Pediatric IBD Justified in the Era of Personalized Medicine — Europe PMC PMID:42278960 — Europe PMC (en), https://europepmc.org/article/MED/42278960 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_e654688eaa97 (Metraipolis archive dc_e654688eaa97, sha256 1640b05e54acc443b14a134cb2496e57fc1727ab18da65c37510445843e4d771)
BibTeX
@misc{dce654688eaa97,
  title = {Is Routine Monitoring of TNF-α Inhibitor Levels and Antibodies in Pediatric IBD Justified in the Era of Personalized Medicine — Europe PMC PMID:42278960},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42278960},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_e654688eaa97; sha256 1640b05e54acc443b14a134cb2496e57fc1727ab18da65c37510445843e4d771},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42278960. Agents can read the archived copy with the MCP tool read_document.